Beneficiaries of Medicare who develop cancer and don’t have supplemental health insurance incur out-of-pocket expenditures for their treatments averaging one-quarter of their income with some paying as high as 63 percent, according to results of a survey-based study published in JAMA Oncology.
Researchers at the Johns Hopkins Bloomberg School of Public Health (JHSPH) and the Johns Hopkins Kimmel Cancer Center said their study shows that a cancer diagnosis can be a serious financial hardship for many elderly and people with disabilities who receive Medicare, with annual out-of-pocket costs ranging from $2,116 to $8,115, on top of the cost of health insurance. The research shows that hospitalizations are a major driver of out-of-pocket costs.
Cancer treatment contributes more to healthcare costs in the United States than treatment for any other disease, said the researchers.
“The spending associated with a new cancer diagnosis gets very high quickly, even if you have insurance,” said one of the study’s authors, Lauren Hersch Nicholas, PhD, MPP. “The health shock can be followed by financial toxicity. In many cases, doctors can bring you back to health, but it can be tremendously expensive and a lot of treatments are given without a discussion of the costs or the financial consequences.”
For their study, Nicholas and Amol K. Narang, MD, examined data from more than 18,000 Medicare beneficiaries who were interviewed biennially between 2002 and 2012 for the Health and Retirement Survey.
Medicare covers just 80 percent of outpatient health costs and has co-pays of $1,000 for each hospital visit. In the study, 15 percent of participants had Medicare alone. Others had some type of supplemental insurance: 50 percent had a Medigap plan or were still receiving employer or retiree benefits; 20 percent participated in a Medicare HMO; 9 percent received Medicaid (the federal plan for the poorest Americans); and 6 percent got benefits from the Veterans Administration (VA). Each type of insurance covers a varying amount of the costs that Medicare doesn’t cover.
The researchers found that the average annual out-of-pocket costs associated with a new cancer diagnosis were $2,116 for Medicaid beneficiaries; $2,367 for the VA; $5,492 for those with employer-sponsored plans; $5,670 for those with Medigap; $5,976 for those with a Medicare HMO; and $8,115 for those without supplemental insurance of any kind. There are no caps on how much Medicare beneficiaries can be asked to pay.
Survey respondents without supplemental insurance reported that their average annual out-of-pocket costs were one-quarter of their annual income and, of those, 10 percent reported that those costs were at least 63 percent of annual income.
“Cancer costs are high, and a significant segment of our seniors who don’t have adequate insurance coverage can be hit hard by this,” Narang said. “In addition to efforts aimed at lowering cancer costs, we need to think about how to offer our seniors better insurance coverage.”
The researchers said one solution, though expensive, would be to cap the amount of out-of-pocket costs a patient can be charged each year. Many private insurance plans have such caps, known as catastrophic coverage. Congress would need to enact such a reform.
“We should expect to spend some of our income on healthcare,” Nicholas said. “But many people are unprepared to spend more than a quarter of their income treating a single disease. The physical disease is terrible, and then you have to figure out how to deal with the economic fallout associated with paying to treat it.”
This article was adapted from information provided by JHSPH.
